Rajesh Vooturi, Ph.D. (he/him/his)

Aurigene Pharmaceutical Services Limited, India

Poster(s):

• (T1530-02-09) Development of a Stable Intravenous Injectable Formulation of Highly Hydrolytic Molecule in a Co-Crystal with a Highly Hydrophobic (A1) and Highly Hydrophilic (A2) Drug Substance
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET

• (W1230-11-72) Formulation Development of Programmable Drug Delivery Multi-Unit Systems for the Delayed and Extended Release of Fixed Dose Combination Drugs
  Wednesday, October 25, 2023

  12:30 PM – 1:30 PM ET